Obesity and type 2 diabetes: Also linked in therapeutic options

被引：33
作者：
Rubio-Almanza, Matilde [1 ,2 ]
Camara-Gomez, Rosa [1 ,2 ]
Francisco Merino-Torres, Juan [1 ,2 ]
机构：
[1] Hosp Univ & Politecn La Fe, Serv Endocrinol & Nutr, Valencia, Spain
[2] Hosp Univ & Politecn La Fe, Unidad Mixta Invest Endocrinol Nutr & Dietet Clin, Valencia, Spain
来源：
ENDOCRINOLOGIA DIABETES Y NUTRICION | 2019年 / 66卷 / 03期
关键词：
Type; 2; diabetes; Obesity; Bariatric surgery; Metabolic surgery; Antiobesity drugs; Clinical trials; Y GASTRIC BYPASS; INTENSIVE MEDICAL THERAPY; LIFE-STYLE INTERVENTION; BARIATRIC SURGERY; WEIGHT-LOSS; GLYCEMIC CONTROL; METABOLIC SURGERY; CARDIOVASCULAR OUTCOMES; STAGING SYSTEM; DOUBLE-BLIND;
D O I：
10.1016/j.endinu.2018.08.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The prevalence of obesity has increased worldwide over the past decades. Obesity is associated with multiple comorbidities, such as type 2 diabetes, that generates a great impact on health and economy. Weight loss in these patients leads to glycemic control so it is a target to achieve. Lifestyle changes are not effective enough and recently other treatments have been developed such as bariatric/metabolic surgery, as well as drugs for type 2 diabetes and antiobesity drugs. The aim of this review is to compare the results in weight reduction and glycemic control of the different kinds of drugs with bariatric / metabolic surgery's results in type 2 diabetes. (C) 2018 SEEN y SED. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码：140 / 149
页数：10
相关论文
共 90 条
[1]   Effects of metformin on energy intake and satiety in obese children [J].
Adeyemo, M. A. ;
McDuffie, J. R. ;
Kozlosky, M. ;
Krakoff, J. ;
Calis, K. A. ;
Brady, S. M. ;
Yanovski, J. A. .
DIABETES OBESITY & METABOLISM, 2015, 17 (04) :363-370
[2]   Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial [J].
Ahmann, Andrew J. ;
Capehorn, Matthew ;
Charpentier, Guillaume ;
Dotta, Francesco ;
Henkel, Elena ;
Lingvay, Ildiko ;
Holst, Anders G. ;
Annett, Miriam P. ;
Aroda, Vanita R. .
DIABETES CARE, 2018, 41 (02) :258-266
[3]   Effect of orlistat on glycaemic control in overweight and obese patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials [J].
Aldekhail, N. M. ;
Logue, J. ;
McLoone, P. ;
Morrison, D. S. .
OBESITY REVIEWS, 2015, 16 (12) :1071-1080
[4]   Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2018 [J].
不详 .
DIABETES CARE, 2018, 41 :S65-S72
[5]   The Gut Microbiota as a Mediator of Metabolic Benefits after Bariatric Surgery [J].
Anhe, Fernando F. ;
Varin, Thibault V. ;
Schertzer, Jonathan D. ;
Marette, Andre .
CANADIAN JOURNAL OF DIABETES, 2017, 41 (04) :439-447
[6]  
[Anonymous], LANCET DIABETES ENDO
[7]  
[Anonymous], OBESITY S1
[8]  
[Anonymous], OB Y SOBR
[9]   Evaluation of Phentermine and Topiramate versus Phentermine/Topiramate Extended-Release in Obese Adults [J].
Aronne, Louis J. ;
Wadden, Thomas A. ;
Peterson, Craig ;
Winslow, David ;
Odeh, Sarah ;
Gadde, Kishore M. .
OBESITY, 2013, 21 (11) :2163-2171
[10]   Association Between Bariatric Surgery and Long-term Survival [J].
Arterburn, David E. ;
Olsen, Maren K. ;
Smith, Valerie A. ;
Livingston, Edward H. ;
Van Scoyoc, Lynn ;
Yancy, William S., Jr. ;
Eid, George ;
Weidenbacher, Hollis ;
Maciejewski, Matthew L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (01) :62-70
123456789